Analytical and Biological Variables Influencing Quantitative Hepatitis C Virus (HCV) Measurement in HIV-HCV Coinfection

Analytical and Biological Variables Influencing Quantitative Hepatitis C Virus (HCV) Measurement in HIV-HCV Coinfection

The present review considers issues pertaining to the precision and variability of quantitative hepatitis C virus (HCV) measurement in general, outlines the characteristics of HCV RNA in HIV-HCV coinfection and evaluates those factors which may affect this measure. The clinical relevance of accurate...

Full description

Saved in:

Bibliographic Details
Main Authors:	Curtis Cooper, Paul MacPherson, William Cameron
Format:	Article
Language:	English
Published:	Wiley 2006-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2006/187241
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ethnicity and Spontaneous Clearance of Hepatitis C in HIV-HCV Coinfected Patients
by: Lil Miedzinski, et al.
Published: (2008-01-01)

Hospitalizations and deaths among people coinfected with HIV and HCV
by: Dorota Zarębska-Michaluk, et al.
Published: (2024-11-01)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada.
by: Adam Palayew, et al.
Published: (2021-01-01)

Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
by: Cintia Cevallos, et al.
Published: (2024-01-01)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
by: Daniel Sepúlveda-Crespo, et al.
Published: (2024-08-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting
by: Cristina Guadalupe Román López, et al.
Published: (2024-10-01)

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis
by: Daniel Sepúlveda-Crespo, et al.
Published: (2025-05-01)

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
by: Rubén Martín-Escolano, et al.
Published: (2024-10-01)

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review
by: Paola Di Carlo, et al.
Published: (2015-01-01)

HIV, HBV and HCV Coinfection Prevalence in Iran--A Systematic Review and Meta-Analysis.
by: Fahimeh Bagheri Amiri, et al.
Published: (2016-01-01)

Epidemiological and laboratory analysis of patients coinfected with HTLV-1 and HCV
by: Alexandre Gomes Vizzoni
Published: (2010-12-01)

Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
by: C. Sangrador Pelluz, et al.
Published: (2014-01-01)

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01)

Functional exhaustion of CD4<sup>+</sup>T cells in HIV/HCV coinfected HAART-treated patients
by: V. V. Vlasova, et al.
Published: (2023-06-01)

Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients
by: Geane Flores, et al.
Published: (2025-03-01)

Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
by: Lauren E Kushner, et al.
Published: (2013-01-01)

Distribution of Hepatitis C Risk Factors and HCV Treatment Outcomes among Central Canadian Aboriginal
by: Parmvir Parmar, et al.
Published: (2016-01-01)

Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations
by: N. V. Dunaeva, et al.
Published: (2022-07-01)

Assessment of CD4+ T cell recovery after direct-acting antiviral hepatitis C treatment in HIV/HCV coinfected immunological nonresponders to ART
by: Violetta Vlasova, et al.
Published: (2025-05-01)

Correction for Taylor et al., “Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome”
by: Bryn C. Taylor, et al.
Published: (2025-03-01)

Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
by: Lucy J Garvey, et al.
Published: (2012-01-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
by: A. I. Mazus, et al.
Published: (2021-12-01)

Glances in Immunology of HIV and HCV Infection
by: Maria Giovanna Quaranta, et al.
Published: (2012-01-01)

Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study
by: Claudinei Mesquita da Silva, et al.
Published: (2018-11-01)

Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01)

The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
by: Sheila M Keating, et al.
Published: (2017-01-01)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
by: Evangelista Sagnelli, et al.
Published: (2012-01-01)

Barriers to Hepatitis C Virus Treatment in a Canadian HIV-Hepatitis C Virus Coinfection Tertiary Care Clinic
by: Meaghan McLaren, et al.
Published: (2008-01-01)

HCV Virus and Lymphoid Neoplasms
by: Yutaka Tsutsumi, et al.
Published: (2011-01-01)

Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)

HCV Ab titer and ALT level indicate occult hepatitis C virus infection in treatment-naive HCV Ab-positive and HCV Ab-negative patients: a 3-year prospective cohort study
by: Ming-Ling Chang, et al.
Published: (2025-08-01)

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

Biological Significance of HCV in Various Kinds of Lymphoid Cells
by: Yasuteru Kondo, et al.
Published: (2012-01-01)

The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects.
by: Victoria Cairoli, et al.
Published: (2022-01-01)

Performance of Elecsys<sup>®</sup> HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
by: Prooksa Ananchuensook, et al.
Published: (2024-09-01)

Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm– a model to enhance the HCV continuum of care
by: Per-Erik Klasa, et al.
Published: (2025-03-01)

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
by: Tyng-Yuan Jang, et al.
Published: (2025-08-01)

Distribution and genotyping of hepatitis C virus (HCV) infection in Gansu province, China
by: Qiajun Du, et al.
Published: (2024-03-01)

Impact of HCV elimination on metabolism markers in people living with HIV
by: Andrés Deza de la Casa, et al.
Published: (2025-05-01)